STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 43 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $13,866,000 | -49.4% | 2,858,928 | -37.4% | 8.64% | -11.4% |
| Q2 2018 | $27,394,000 | -2.7% | 4,565,633 | +43.5% | 9.74% | +7.4% |
| Q1 2018 | $28,162,000 | +176.3% | 3,182,149 | +126.3% | 9.07% | +166.9% |
| Q4 2017 | $10,194,000 | +256.2% | 1,406,095 | +239.0% | 3.40% | +208.2% |
| Q3 2017 | $2,862,000 | – | 414,773 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 8,083,442 | $22,310,000 | 14.49% |
| AIGH Capital Management LLC | 2,194,173 | $6,056,000 | 1.27% |
| Worth Venture Partners, LLC | 550,196 | $1,519,000 | 0.74% |
| Stonepine Capital Management, LLC | 445,701 | $1,230,000 | 0.66% |
| NEA Management Company, LLC | 4,141,308 | $11,430,000 | 0.26% |
| Ikarian Capital, LLC | 1,160,450 | $3,203,000 | 0.11% |
| ALGERT GLOBAL LLC | 99,397 | $274,000 | 0.09% |
| Zebra Capital Management LLC | 24,039 | $66,000 | 0.07% |
| HighVista Strategies LLC | 28,432 | $79,000 | 0.06% |
| Orbimed Advisors | 1,744,669 | $4,815,000 | 0.04% |